nitroglycerin has been researched along with lisinopril in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Holubarsch, C | 1 |
| Avanzini, F; De Nicolao, A; Latini, R; Rocchetti, M | 1 |
| Mazzotta, G; Vecchio, C | 1 |
| Franzosi, M; Latini, R; Maggioni, AP; Santoro, L; Tognoni, G; Zuanetti, G | 1 |
| Chiarella, F; Domenicucci, S; Maggioni, A; Santoro, E; Vecchio, C | 1 |
| Buikema, H; Crijns, HJ; de Zeeuw, D; Monnink, SH; Tio, RA; van Gilst, WH | 1 |
| Chedgy, F; Howlett, DC; Inglis, C | 1 |
| Bahde, R; Bandi, S; Bhargava, KK; Gupta, S; Kapoor, S; Palestro, CJ | 1 |
2 review(s) available for nitroglycerin and lisinopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Female; Humans; Injections, Intravenous; Lisinopril; Male; Multicenter Studies as Topic; Myocardial Infarction; Nitroglycerin; Ramipril; Thrombolytic Therapy; Time Factors | 1994 |
7 trial(s) available for nitroglycerin and lisinopril
| Article | Year |
|---|---|
GISSI-3 study protocol on the effects of lisinopril, of nitrates, and of their association in patients with acute myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Protocols; Dipeptides; Drug Combinations; Female; Follow-Up Studies; Heart Failure; Humans; Hypertrophy, Left Ventricular; Informed Consent; Italy; Lisinopril; Myocardial Infarction; Nitroglycerin; Pilot Projects; Survival Rate; Thrombolytic Therapy; Treatment Outcome; Ventricular Function, Left | 1992 |
[GISSI III: the effect of lisinopril and the transdermal application of nitroglycerin after an acute infarct. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
Topics: Administration, Cutaneous; Drug Therapy, Combination; Humans; Italy; Lisinopril; Myocardial Infarction; Nitroglycerin | 1994 |
GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Clinical Protocols; Creatinine; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Humans; Infusions, Intravenous; Lisinopril; Male; Myocardial Infarction; Nitroglycerin; Odds Ratio; Risk Factors; Survival Rate | 1994 |
Effects of lisinopril and nitroglycerin on blood pressure early after myocardial infarction: the GISSI-3 pilot study.
Topics: Aged; Analysis of Variance; Blood Pressure; Female; Humans; Lisinopril; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Pilot Projects; Time Factors | 1994 |
Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardic
Topics: Administration, Cutaneous; Adult; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lisinopril; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Prognosis; Sex Factors; Time Factors; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 1996 |
Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Diabetes Complications; Female; Humans; Lisinopril; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Retrospective Studies; Survival Analysis; Vasodilator Agents | 1997 |
Predischarge two-dimensional echocardiographic evaluation of left ventricular thrombosis after acute myocardial infarction in the GISSI-3 study.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Echocardiography; Female; Heart Diseases; Humans; Incidence; Lisinopril; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Nitroglycerin; Thrombolytic Therapy; Thrombosis; Vasodilator Agents | 1998 |
4 other study(ies) available for nitroglycerin and lisinopril
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
Topics: Acetylcholine; Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Calcimycin; Captopril; Endothelium, Vascular; Heart Diseases; In Vitro Techniques; Lisinopril; Male; Myocardial Infarction; Nitrates; Nitrites; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Wistar; Sodium Nitrite; Sulfhydryl Compounds; Vasodilation; Vasodilator Agents | 2000 |
A case of recurrent ventricular tachycardia.
Topics: Aged; Atorvastatin; Cardiovascular Agents; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heptanoic Acids; Humans; Isosorbide Dinitrate; Lisinopril; Nitroglycerin; Pyrroles; Recurrence; Tachycardia, Ventricular; Warfarin | 2011 |
Directly acting drugs prostacyclin or nitroglycerine and endothelin receptor blocker bosentan improve cell engraftment in rodent liver.
Topics: Animals; Bosentan; Cardiovascular Agents; Dipeptidyl Peptidase 4; Endothelin Receptor Antagonists; Epoprostenol; Hepatocytes; Lisinopril; Liver; Losartan; Nitroglycerin; Rats; Rats, Inbred F344; Sulfonamides | 2013 |